Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46,377,939
-
Total 13F shares
-
20,292,672
-
Share change
-
-152,936
-
Total reported value
-
$362,569,441
-
Price per share
-
$17.87
-
Number of holders
-
100
-
Value change
-
-$2,721,250
-
Number of buys
-
38
-
Number of sells
-
51
Institutional Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q3 2017
As of 30 Sep 2017,
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) was held by
100 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,292,672 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, Invesco Ltd., FEDERATED INVESTORS INC /PA/, STATE STREET CORP, TEACHERS ADVISORS, LLC, NORTHERN TRUST CORP, UBS ASSET MANAGEMENT AMERICAS INC, and Bank of New York Mellon Corp.
This page lists
100
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.